Gene · 2203
Papers2,174
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,174
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TMT-based quantitative proteomic analysis reveals the underlying mechanisms of glycidyl methacrylate-induced 16HBE cell malignant transformation. | Toxicology | 2023 | 36641056 | PubTator, text mining | PubMed |
| SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes. | J Clin Invest | 2023 | 36637914 | PubTator, text mining | PubMed |
| c-Myc-IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming. | Clin Transl Med | 2023 | 36629054 | PubTator, text mining | PubMed |
| Reduced fibrous capsule elastic fibers from biologic ECM-enveloped CIEDs in minipigs, supported with a novel compression mechanics model. | Biomed Mater Eng | 2023 | 36617774 | PubTator, text mining | PubMed |
| Glyphosate based-herbicide disrupts energy metabolism and activates inflammatory response through oxidative stress in mice liver. | Chemosphere | 2023 | 36608876 | PubTator, text mining | PubMed |
| NetSHy: network summarization via a hybrid approach leveraging topological properties. | Bioinformatics | 2023 | 36548341 | PubTator, text mining | PubMed |
| FBP1 induced by β-elemene enhances the sensitivity of gefitinib in lung cancer. | Thorac Cancer | 2023 | 36525508 | PubTator, text mining | PubMed |
| Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy. | Cancer Gene Ther | 2023 | 36494582 | PubTator, text mining | PubMed |
| Functions and modulation of PKM2 activity by human papillomavirus E7 oncoprotein (Review). | Oncol Lett | 2023 | 36478899 | PubTator, text mining | PubMed |
| Metformin suppresses SARS-CoV-2 in cell culture. | Virus Res | 2023 | 36417940 | PubTator, text mining | PubMed |
| Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase. | Chembiochem | 2023 | 36250581 | PubTator, text mining | PubMed |
| Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention. | Cell Prolif | 2023 | 36229407 | PubTator, text mining | PubMed |
| Global ubiquitinome analysis reveals the role of E3 ubiquitin ligase FaBRIZ in strawberry fruit ripening. | J Exp Bot | 2023 | 36215033 | PubTator, text mining | PubMed |
| COVID-19 immunopathology: From acute diseases to chronic sequelae. | J Med Virol | 2023 | 36056655 | PubTator, text mining | PubMed |
| IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease. | J Hepatol | 2023 | 36049612 | PubTator, text mining | PubMed |
| Regulation of tumor metabolism by post translational modifications on metabolic enzymes. | Cancer Gene Ther | 2023 | 35999357 | PubTator, text mining | PubMed |
| Construction of a prognostic glycolysis-related lncRNA signature for patients with colorectal cancer. | Cancer Med | 2023 | 35616307 | PubTator, text mining | PubMed |
| The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes. | J Liver Cancer | 2022 | 37383409 | PubTator, text mining | PubMed |
| Recurrent Encephalopathy with Metabolic Acidosis and Hypoglycemia: Do not Forget Fructose Metabolism. | Ann Indian Acad Neurol | 2022 | 36911435 | PubTator, text mining | PubMed |
Utility of Fluorine18 Fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography in Metabolic Characterization of Solid Renal Mass Lesion and Localization of Extra Renal Lesions in the Body - A Prospective Study from the Tertiary Care Center in South India. | Indian J Nucl Med | 2022 | 36817204 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2203/papers?page=20